Affiliation:
1. From the Department of Pathology and Molecular Medicine and the Department of Medicine, McMaster University, Hamilton, ON, Canada; and the Department of Hematology and Oncology, Hôpital Sainte Justine, Montreal, QC, Canada.
Abstract
Abstract
Quebec platelet disorder (QPD) is an autosomal dominant bleeding disorder associated with increased urokinase-type plasminogen activator in platelets and α-granule protein degradation. To determine bleeding risks and common manifestations of QPD, a history questionnaire was developed and administered to 127 relatives in a family with QPD. Data entry was done blinded to affected and unaffected status, determined by assays for platelet urokinase-type plasminogen activator (u-PA) and fibrinogen degradation. Odds ratios (ORs), with 95% confidence intervals (CIs), were determined for items queried. Summative bleeding scores for each individual were calculated using items with OR more than 1. Mean ages (34 years; range, 1-89 years) were similar for affected (n = 23) and unaffected (n = 104) family members. Affected individuals had higher mean bleeding scores (P < .0001) and a much higher likelihood (OR > 20) of having bleeding that led to lifestyle changes, bruises that spread lower or as large or larger than an orange or both, joint bleeds, bleeding longer than 24 hours after dental extractions or deep cuts, and received or been recommended other treatments (fibrinolytic inhibitors) for bleeding. Individuals with QPD and exposure(s) to hemostatic challenges had experienced excessive bleeding only when fibrinolytic inhibitors had not been used. These data illustrate that QPD is associated with increased risks of bleeding that can be modified by fibrinolytic inhibitors.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Reference22 articles.
1. Hayward CPM. Inherited platelet disorders. Curr Opin Hematol. 2003;10: 362-368.
2. Šrámek A, Eikenboom JCJ, Briët E, Vandenbrouke JP, Rosendaal FR. Usefulness of patient interview in bleeding disorders. Arch Int Med. 1995; 155: 1409-1415.
3. Sadler JE, Blinder M. Diagnosis and classification of von Willebrand disease. In: Coleman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams and Wilkins; 2001: 825-837.
4. Hayward CPM. Extending knowledge on inherited platelet disorders associated with thrombocytopenia. Thromb Haemost. 2003;90: 770-771.
5. Lee CA. Women and inherited bleeding disorders: menstrual losses. Semin Hematol. 1999; 3(suppl 4): 21-27.
Cited by
95 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献